{"data":{"ticker":"RARE","name":"Ultragenyx Pharmaceutical Inc.","cik":"0001515673","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":98052000,"netIncome":-159649000,"epsDiluted":-2.23,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":127143000,"netIncome":-123551000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":108833000,"netIncome":-170684000,"epsDiluted":-2.03,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":147026000,"netIncome":-131598000,"epsDiluted":-1.52,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":139494000,"netIncome":-133516000,"epsDiluted":-1.4,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":164647000,"netIncome":-133202000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":139000000,"netIncome":-151000000,"epsDiluted":-1.57,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":167000000,"netIncome":-115000000,"epsDiluted":-1.17,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":159933000,"netIncome":-180413000,"epsDiluted":-1.81,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":207067000,"netIncome":-128587000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":136000000,"netIncome":-185000000,"epsDiluted":-1.84,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":214000000,"netIncome":-92000000,"epsDiluted":-0.9,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":271030000,"netIncome":-186566000,"operatingCashFlow":-132220000,"capex":43905000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":351406000,"netIncome":-454025000,"operatingCashFlow":-338695000,"capex":73093000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":363329000,"netIncome":-707421000,"operatingCashFlow":-380465000,"capex":116123000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":434000000,"netIncome":-607000000,"operatingCashFlow":-475000000,"capex":44000000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":560000000,"netIncome":-569000000,"operatingCashFlow":-414000000,"capex":7000000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":673000000,"netIncome":-575000000,"operatingCashFlow":-466000000,"capex":6000000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":125000000,"debt":null,"equity":-291000000,"assets":1264000000,"sharesOutstanding":98588873,"sharesDate":"2026-07-31","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-10-14T20:58:33.724Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}